EUVIMEDEUVIMED entdecken
Open Access

Inhibition of nucleolar transcription by oxaliplatin involves ATM/ATR kinase signaling

Misha Nechay, Danyang Wang, Ralph E Kleiner

Cell Chemical Biology · 2023-08 · 30 (8) · 906-919.e4

DOI: 10.1016/j.chembiol.2023.06.010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Chemical Biology, 2023-08. Verfasst von Misha Nechay und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Princeton University, Princeton, NJ 08544, USA. Hauptthemen laut MEDLINE: Transcription, Genetic, DNA Damage. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, Princeton University, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Platinum (Pt) compounds are an important class of anti-cancer therapeutics, but outstanding questions remain regarding their mechanism of action. Here, we demonstrate that oxaliplatin, a Pt drug used to treat colorectal cancer, inhibits rRNA transcription through ATM and ATR signaling, and induces DNA damage and nucleolar disruption. We show that oxaliplatin causes nucleolar accumulation of the nucleolar DNA damage response proteins (n-DDR) NBS1 and TOPBP1; however transcriptional inhibition does not depend upon NBS1 or TOPBP1, nor does oxaliplatin induce substantial amounts of nucleolar DNA damage, distinguishing the nucleolar response from previously characterized n-DDR pathways. Taken together, our work indicates that oxaliplatin induces a distinct ATM and ATR signaling pathway that functions to inhibit Pol I transcription in the absence of direct nucleolar DNA damage, demonstrating how nucleolar stress and transcriptional silencing can be linked to DNA damage signaling and highlighting an important mechanism of Pt drug cytotoxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcription, GeneticDNA DamageOxaliplatinAtaxia Telangiectasia Mutated ProteinsNuclear ProteinsSignal Transduction

Stichwörter der Autor:innen

DNA damage responsenucleolus" RNA pol Ioxaliplatin

Substanzen

OxaliplatinAtaxia Telangiectasia Mutated ProteinsNuclear Proteins

Autor:innen und Institutionen

  • Department of Chemistry, Princeton University, Princeton, NJ 08544, USA.
  • Department of Chemistry, Princeton University, Princeton, NJ 08544, USA. Electronic address: rkleiner@princeton.edu.

Förderung

  • NIGMS NIH HHS
  • Princeton University
  • National Institutes of Health
  • National Institute of General Medical Sciences
  • Alfred P. Sloan Foundation

Zitieren

APA

Nechay, M., Wang, D., & Kleiner, R. E. (2023). Inhibition of nucleolar transcription by oxaliplatin involves ATM/ATR kinase signaling. Cell Chemical Biology, 30(8), 906-919.e4. https://doi.org/10.1016/j.chembiol.2023.06.010

Vancouver

Nechay M, Wang D, Kleiner RE. Inhibition of nucleolar transcription by oxaliplatin involves ATM/ATR kinase signaling. Cell Chemical Biology. 2023;30(8):906-919.e4. doi:10.1016/j.chembiol.2023.06.010

BibTeX
@article{Nechay2023,
  author = {Nechay, Misha and Wang, Danyang and Kleiner, Ralph E},
  title = {Inhibition of nucleolar transcription by oxaliplatin involves ATM/ATR kinase signaling},
  journal = {Cell Chemical Biology},
  year = {2023},
  volume = {30},
  number = {8},
  pages = {906--919.e4},
  doi = {10.1016/j.chembiol.2023.06.010}
}
Kostenlos starten →